文献速递神经免疫认知障碍与痴呆

DPPX抗体相关脑炎的主要综合征及抗体效应

DPPX antibody-associated encephalitis: Main syndrome and antibody effects.
PubMed 文献 · Neurology · 2017-03-03

该研究回顾性分析了9例新发及2013年以来报告的DPPX抗体脑炎病例,发现所有患者均出现严重前驱体重下降或腹泻,随后出现认知障碍、中枢神经系统过度兴奋或脑干/小脑功能障碍;抗体以IgG4和IgG1为主,在培养神经元中可逆性减少DPPX簇和Kv4.2蛋白;综合39例病例,67%出现体重下降/胃肠道症状、认知-精神障碍和中枢神经系统过度兴奋三联征;免疫治疗可改善预后,复发对免疫治疗有反应。

要点

  • DPPX抗体脑炎典型表现为前驱体重下降/腹泻后出现认知障碍和中枢过度兴奋。
  • 抗体主要为IgG1和IgG4,可可逆性减少培养神经元DPPX簇和Kv4.2蛋白。
  • 免疫治疗有效,多数患者改善,复发对免疫治疗仍有反应。

核心结论

  • DPPX抗体以IgG1和IgG4为主,与认知-精神障碍和中枢神经系统过度兴奋相关,常先有腹泻、其他胃肠道症状和体重下降。
  • 该病对免疫治疗有反应,培养神经元中抗体效应的可逆性支持这一结论。

研究设计与样本

  • 回顾性分析新发患者及2013年以来报告的病例,共9例新患者(中位年龄57岁,范围36-69岁)。
  • 采用既定技术测定IgG亚型及抗体对培养神经元的影响。

主要发现

  • 9例新患者均出现严重前驱体重下降或腹泻,随后出现认知功能障碍(9例)、记忆缺陷(5例)、中枢神经系统过度兴奋(8例;过度惊跳、肌阵挛、震颤或癫痫发作)或脑干/小脑功能障碍(7例)。
  • 疾病高峰在发病后8个月(范围1-54个月)达到。
  • 所有患者均有IgG4和IgG1 DPPX抗体;在培养神经元中,抗体导致DPPX簇和Kv4.2蛋白减少,去除抗体后可逆。
  • 结合当前系列和既往报告病例(共39例),67%出现三联征:体重下降(中位20 kg;范围8-53 kg)/胃肠道症状、认知-精神功能障碍和中枢神经系统过度兴奋。
  • 35例有结局数据(8例未接受免疫治疗):60%显著或中度改善,23%无改善(多数未治疗),17%死亡;35例中8例(23%)复发,对免疫治疗有反应。

临床怎么用

  • 对伴有前驱体重下降或腹泻、随后出现认知障碍和中枢神经系统过度兴奋的患者,应考虑检测DPPX抗体。
  • DPPX抗体脑炎应尽早给予免疫治疗,复发时免疫治疗仍可能有效。

局限性

  • 回顾性分析,部分病例来自既往报告,可能存在选择偏倚。
  • 35例有结局数据,其中8例未接受免疫治疗,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To report the main syndrome of dipeptidyl-peptidase-like protein 6 (DPPX) antibody-associated encephalitis, immunoglobulin G (IgG) subclass, and the antibody effects on DPPX/Kv4.2 potassium channels. METHODS: A retrospective analysis of new patients and cases reported since 2013 was performed. IgG subclass and effects of antibodies on cultured neurons were determined with described techniques. RESULTS: Nine new patients were identified (median age 57 years, range 36-69 years). All developed severe prodromal weight loss or diarrhea followed by cognitive dysfunction (9), memory deficits (5), CNS hyperexcitability (8; hyperekplexia, myoclonus, tremor, or seizures), or brainstem or cerebellar dysfunction (7). The peak of the disease was reached 8 months (range 1-54 months) after onset. All patients had both IgG4 and IgG1 DPPX antibodies. In cultured neurons, the antibodies caused a decrease of DPPX clusters and Kv4.2 protein that was reversible on removal of the antibodies. Considering the current series and previously reported cases (total 39), 67% developed the triad: weight loss (median 20 kg; range 8-53 kg)/gastrointestinal symptoms, cognitive-mental dysfunction, and CNS hyperexcitability. Outcome was available from 35 patients (8 not treated with immunotherapy): 60% had substantial or moderate improvement, 23% had no improvement (most of them not treated), and 17% died. Relapses occurred in 8 of 35 patients (23%) and were responsive to immunotherapy. CONCLUSIONS: DPPX antibodies are predominantly IgG1 and IgG4 and associate with cognitive-mental deficits and symptoms of CNS hyperexcitability that are usually preceded by diarrhea, other gastrointestinal symptoms, and weight loss. The disorder is responsive to immunotherapy, and this is supported by the reversibility of the antibody effects in cultured neurons.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Hara M, Ariño H, Petit-Pedrol M, et al. DPPX antibody-associated encephalitis: Main syndrome and antibody effects. Neurology. 2017. PMID: 28258082. doi:10.1212/WNL.0000000000003796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。